MedTrace Logo

Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment

NCT01814189 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2013-07-30

No results posted yet for this study

Summary

The purpose of this study is to show the efficacy of promethazine in management of patients with moderate to severe migraine

Conditions

  • Migraine With Aura
  • Migraine Without Aura

Interventions

DRUG

Sumatriptan+Promethazine (SPr)

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01814189 on ClinicalTrials.gov